Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support services; Warehousing, including dedicated storage, shared warehouses, packing and value-added services, such as labeling and products assembly; Logistics systems, including software for logistics management; Passenger transportation, including transportation of personnel and students; Special services, including rental of bus and vans; Moving, including national and international moving services, and Advertising, including custom transportation services during marketing campaigns. The Company operates through a number of group companies.


PINL:GRPOF - Post by User

Post by Humaniston May 29, 2020 9:23am
226 Views
Post# 31086800

Expect delays in non-Covid clinical trials, former FDA chief

Expect delays in non-Covid clinical trials, former FDA chiefhttps://www.cnbc.com/2020/05/29/coronavirus-live-updates.html
May 29, 2020/ 7:20 a.m. ET —

Clinical trials of drugs, treatments and vaccines unrelated to Covid-19 will likely face delays going forward as the agency focuses its resources on addressing the virus, former Food and Drug Administration Commissioner Dr. Scott Gottlieb said.

“A lot of drug companies put clinical trials on hold,” he said, adding that some companies didn’t go forward with planned trials and others suspended ongoing trials. “The agency has been keeping up” so far, Gottlieb added.

The FDA put out new guidance dated May 26 that said the agency might need to prioritize resources moving forward as staff is stretched thin. 

“With many staff members working on COVID-19 activities, it is possible that we will not be able to sustain our current performance level in meeting goal dates indefinitely,” the agency said in the document. —Will Feuer

Disclosure: Scott Gottlieb is a CNBC contributor and is a member of the boards of Pfizer and biotech company Illumina.


<< Previous
Bullboard Posts
Next >>